Protara Therapeutics, Inc.TARANASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank100
3Y CAGR+85.7%
5Y CAGR+72.5%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+85.7%/yr
vs +14.6%/yr prior
5Y CAGR
+72.5%/yr
Recent acceleration
Acceleration
+71.1pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
15.3x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$7.11M+56.0%
2024$4.56M+42.7%
2023$3.19M+187.7%
2022$1.11M+368.4%
2021$237000.00-49.1%
2020$466000.00-
2019$0.00-100.0%
2018$643000.00+61.6%
2017$398000.00+122.3%
2016$179000.00-